Annual EBIT
-$31.21 M
+$312.60 K+0.99%
31 December 2023
Summary:
Cytosorbents annual earnings before interest & taxes is currently -$31.21 million, with the most recent change of +$312.60 thousand (+0.99%) on 31 December 2023. During the last 3 years, it has fallen by -$20.84 million (-200.95%). CTSO annual EBIT is now -1049.01% below its all-time high of $3.39 million.CTSO EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EBIT
-$1.75 M
+$1.67 M+48.93%
30 September 2024
Summary:
Cytosorbents quarterly earnings before interest & taxes is currently -$1.75 million, with the most recent change of +$1.67 million (+48.93%) on 30 September 2024. Over the past year, it has increased by +$7.41 million (+80.94%). CTSO quarterly EBIT is now -131.08% below its all-time high of $5.62 million, reached on 31 December 2008.CTSO Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EBIT
-$18.73 M
+$7.41 M+28.36%
30 September 2024
Summary:
Cytosorbents TTM earnings before interest & taxes is currently -$18.73 million, with the most recent change of +$7.41 million (+28.36%) on 30 September 2024. Over the past year, it has increased by +$11.23 million (+37.49%). CTSO TTM EBIT is now -481.42% below its all-time high of $4.91 million, reached on 31 December 2008.CTSO TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CTSO EBIT Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +1.0% | +80.9% | +37.5% |
| 3 y3 years | -200.9% | +67.7% | -1.0% |
| 5 y5 years | -90.7% | +73.5% | +8.3% |
CTSO EBIT High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -200.9% | +1.0% | at high | +81.7% | -1.0% | +46.1% |
| 5 y | 5 years | -200.9% | +1.0% | -201.5% | +81.7% | -80.6% | +46.1% |
| alltime | all time | -1049.0% | +1.0% | -131.1% | +81.7% | -481.4% | +46.1% |
Cytosorbents EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$1.75 M(-48.9%) | -$18.73 M(-28.4%) |
| June 2024 | - | -$3.42 M(-30.6%) | -$26.15 M(-10.7%) |
| Mar 2024 | - | -$4.93 M(-43.0%) | -$29.29 M(-9.2%) |
| Dec 2023 | -$31.21 M(-1.0%) | -$8.64 M(-5.6%) | -$32.25 M(+7.6%) |
| Sept 2023 | - | -$9.16 M(+39.6%) | -$29.97 M(+0.5%) |
| June 2023 | - | -$6.56 M(-16.9%) | -$29.82 M(-5.7%) |
| Mar 2023 | - | -$7.89 M(+24.2%) | -$31.62 M(+0.3%) |
| Dec 2022 | -$31.52 M(+38.6%) | -$6.36 M(-29.5%) | -$31.52 M(-9.2%) |
| Sept 2022 | - | -$9.02 M(+7.9%) | -$34.73 M(+11.6%) |
| June 2022 | - | -$8.36 M(+7.3%) | -$31.12 M(+12.4%) |
| Mar 2022 | - | -$7.79 M(-18.5%) | -$27.68 M(+15.1%) |
| Dec 2021 | -$22.74 M(+119.3%) | -$9.56 M(+76.9%) | -$24.05 M(+29.7%) |
| Sept 2021 | - | -$5.41 M(+9.8%) | -$18.54 M(+35.2%) |
| June 2021 | - | -$4.92 M(+18.4%) | -$13.71 M(+20.5%) |
| Mar 2021 | - | -$4.16 M(+2.6%) | -$11.38 M(+9.7%) |
| Dec 2020 | -$10.37 M(-46.3%) | -$4.05 M(+599.5%) | -$10.37 M(-6.1%) |
| Sept 2020 | - | -$579.10 K(-77.7%) | -$11.05 M(-35.2%) |
| June 2020 | - | -$2.59 M(-17.6%) | -$17.05 M(-4.2%) |
| Mar 2020 | - | -$3.15 M(-33.5%) | -$17.79 M(-7.9%) |
| Dec 2019 | -$19.32 M(+18.0%) | -$4.73 M(-28.2%) | -$19.32 M(-5.4%) |
| Sept 2019 | - | -$6.58 M(+97.5%) | -$20.42 M(+22.6%) |
| June 2019 | - | -$3.33 M(-28.8%) | -$16.66 M(-9.0%) |
| Mar 2019 | - | -$4.68 M(-19.7%) | -$18.31 M(+9.4%) |
| Dec 2018 | -$16.37 M(+95.1%) | -$5.83 M(+106.6%) | -$16.73 M(+15.6%) |
| Sept 2018 | - | -$2.82 M(-43.4%) | -$14.47 M(+7.6%) |
| June 2018 | - | -$4.98 M(+60.6%) | -$13.46 M(+33.4%) |
| Mar 2018 | - | -$3.10 M(-13.2%) | -$10.09 M(+20.2%) |
| Dec 2017 | -$8.39 M(-29.2%) | -$3.57 M(+98.4%) | -$8.39 M(-15.4%) |
| Sept 2017 | - | -$1.80 M(+11.7%) | -$9.92 M(-2.7%) |
| June 2017 | - | -$1.61 M(+14.7%) | -$10.19 M(-9.6%) |
| Mar 2017 | - | -$1.40 M(-72.5%) | -$11.27 M(-5.7%) |
| Dec 2016 | -$11.85 M(+27.4%) | -$5.10 M(+146.5%) | -$11.95 M(+25.7%) |
| Sept 2016 | - | -$2.07 M(-22.9%) | -$9.51 M(-0.8%) |
| June 2016 | - | -$2.69 M(+28.6%) | -$9.59 M(+5.0%) |
| Mar 2016 | - | -$2.09 M(-21.5%) | -$9.13 M(-1.9%) |
| Dec 2015 | -$9.30 M | -$2.66 M(+23.8%) | -$9.30 M(-2.5%) |
| Sept 2015 | - | -$2.15 M(-3.5%) | -$9.54 M(+7.5%) |
| June 2015 | - | -$2.23 M(-1.6%) | -$8.88 M(+10.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2015 | - | -$2.26 M(-22.1%) | -$8.01 M(+16.1%) |
| Dec 2014 | -$6.89 M(+46.2%) | -$2.90 M(+95.7%) | -$6.90 M(+37.9%) |
| Sept 2014 | - | -$1.48 M(+8.8%) | -$5.01 M(+13.7%) |
| June 2014 | - | -$1.36 M(+18.1%) | -$4.40 M(-1.0%) |
| Mar 2014 | - | -$1.15 M(+14.9%) | -$4.45 M(-5.7%) |
| Dec 2013 | -$4.71 M(+35.0%) | -$1.00 M(+14.2%) | -$4.71 M(+4.2%) |
| Sept 2013 | - | -$879.80 K(-37.5%) | -$4.52 M(+6.6%) |
| June 2013 | - | -$1.41 M(-1.1%) | -$4.24 M(+10.3%) |
| Mar 2013 | - | -$1.42 M(+75.0%) | -$3.85 M(+10.2%) |
| Dec 2012 | -$3.49 M(-21.3%) | -$812.90 K(+35.2%) | -$3.49 M(-4.3%) |
| Sept 2012 | - | -$601.20 K(-40.4%) | -$3.65 M(-14.6%) |
| June 2012 | - | -$1.01 M(-5.4%) | -$4.27 M(-2.4%) |
| Mar 2012 | - | -$1.07 M(+10.2%) | -$4.38 M(-1.4%) |
| Dec 2011 | -$4.44 M(+57.1%) | -$968.40 K(-21.0%) | -$4.44 M(+14.7%) |
| Sept 2011 | - | -$1.23 M(+10.0%) | -$3.87 M(+13.0%) |
| June 2011 | - | -$1.11 M(-1.3%) | -$3.42 M(+14.7%) |
| Mar 2011 | - | -$1.13 M(+181.3%) | -$2.98 M(+5.7%) |
| Dec 2010 | -$2.82 M(-192.8%) | -$401.20 K(-48.6%) | -$2.82 M(-191.7%) |
| Sept 2010 | - | -$780.70 K(+15.8%) | $3.08 M(+2.0%) |
| June 2010 | - | -$674.40 K(-30.3%) | $3.02 M(+6.3%) |
| Mar 2010 | - | -$967.80 K(-117.6%) | $2.84 M(-6.6%) |
| Dec 2009 | $3.04 M(-7.4%) | $5.50 M(-754.7%) | $3.04 M(-3.6%) |
| Sept 2009 | - | -$840.60 K(-1.5%) | $3.16 M(+0.9%) |
| June 2009 | - | -$853.30 K(+11.5%) | $3.13 M(-34.7%) |
| Mar 2009 | - | -$765.60 K(-113.6%) | $4.79 M(-2.4%) |
| Dec 2008 | $3.29 M(-207.2%) | $5.62 M(-745.4%) | $4.91 M(-475.3%) |
| Sept 2008 | - | -$870.30 K(-207.3%) | -$1.31 M(+16.4%) |
| June 2008 | - | $811.30 K(-225.5%) | -$1.12 M(-56.0%) |
| Mar 2008 | - | -$646.60 K(+7.2%) | -$2.55 M(-16.7%) |
| Dec 2007 | -$3.07 M(+3.5%) | -$603.20 K(-12.1%) | -$3.07 M(-8.9%) |
| Sept 2007 | - | -$686.20 K(+11.1%) | -$3.37 M(+0.5%) |
| June 2007 | - | -$617.90 K(-46.7%) | -$3.35 M(+1.1%) |
| Mar 2007 | - | -$1.16 M(+28.4%) | -$3.31 M(+53.1%) |
| Dec 2006 | -$2.96 M | -$903.00 K(+35.1%) | -$2.16 M(+70.6%) |
| Sept 2006 | - | -$668.50 K(+15.0%) | -$1.27 M(-10.1%) |
| June 2006 | - | -$581.40 K(+5772.7%) | -$1.41 M(+70.1%) |
| Feb 2006 | - | -$9900.00(+25.3%) | -$829.10 K(+1.2%) |
| Nov 2005 | - | -$7900.00(-99.0%) | -$819.20 K(+1.0%) |
| Aug 2005 | - | -$811.30 K | -$811.30 K |
FAQ
- What is Cytosorbents annual earnings before interest & taxes?
- What is the all time high annual EBIT for Cytosorbents?
- What is Cytosorbents annual EBIT year-on-year change?
- What is Cytosorbents quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Cytosorbents?
- What is Cytosorbents quarterly EBIT year-on-year change?
- What is Cytosorbents TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Cytosorbents?
- What is Cytosorbents TTM EBIT year-on-year change?
What is Cytosorbents annual earnings before interest & taxes?
The current annual EBIT of CTSO is -$31.21 M
What is the all time high annual EBIT for Cytosorbents?
Cytosorbents all-time high annual earnings before interest & taxes is $3.39 M
What is Cytosorbents annual EBIT year-on-year change?
Over the past year, CTSO annual earnings before interest & taxes has changed by +$312.60 K (+0.99%)
What is Cytosorbents quarterly earnings before interest & taxes?
The current quarterly EBIT of CTSO is -$1.75 M
What is the all time high quarterly EBIT for Cytosorbents?
Cytosorbents all-time high quarterly earnings before interest & taxes is $5.62 M
What is Cytosorbents quarterly EBIT year-on-year change?
Over the past year, CTSO quarterly earnings before interest & taxes has changed by +$7.41 M (+80.94%)
What is Cytosorbents TTM earnings before interest & taxes?
The current TTM EBIT of CTSO is -$18.73 M
What is the all time high TTM EBIT for Cytosorbents?
Cytosorbents all-time high TTM earnings before interest & taxes is $4.91 M
What is Cytosorbents TTM EBIT year-on-year change?
Over the past year, CTSO TTM earnings before interest & taxes has changed by +$11.23 M (+37.49%)